Mia's Feed
Medical News & Research

AI-Driven Robotic Echocardiograms Could Reduce Waiting Times and Improve Cardiac Care Access

AI-Driven Robotic Echocardiograms Could Reduce Waiting Times and Improve Cardiac Care Access

Share this article

Innovative AI-controlled robotic echocardiogram systems could revolutionize heart imaging by reducing wait times and expanding access, addressing current NHS staffing shortages.

2 min read

Researchers at Cranfield University, in collaboration with Milton Keynes University Hospital, have developed an innovative AI-controlled robotic system to perform echocardiograms—urgent ultrasound tests used to assess heart health. This advancement aims to address the growing challenge faced by the UK's National Health Service (NHS), which struggles with a significant shortage of trained sonographers. The current vacancy rate for these specialists has doubled from 6.7% in 2019 to 13.4% in 2023, driven by increased demand, staffing difficulties, and health issues like repetitive strain injuries affecting practitioners.

The new system employs a robotic arm equipped with an imaging probe, paired with sophisticated AI software that evaluates image quality in real-time. The process begins with a human operator placing the probe on the patient's skin. The robot then autonomously executes a spiral scanning pattern, adjusting its position and orientation based on continuous feedback to optimize image clarity. This autonomous adjustment is guided by AI, which assesses the images as they are captured to ensure they meet diagnostic standards.

In initial tests, the system successfully achieved an 80% accuracy rate in obtaining the standard four-chamber view (A4Ch) of the heart, demonstrating its potential to perform reliable assessments. Such automation could dramatically reduce waiting times for cardiac imaging, especially important in community health settings where access to specialist staff is limited.

Professor Yifan Zhao, a data science expert at Cranfield University, emphasized the transformative potential of this AI-driven approach, noting that it could enable more accessible testing outside traditional hospital environments, alleviating the pressure on NHS facilities. Similarly, Dr. Gilbert Tang, a robotics specialist, highlighted that improving the technology's accuracy could lead to more consistent diagnoses and better patient outcomes.

Milton Keynes University Hospital’s cardiologist, Professor Attila Kardos, saw this innovation as a promising step toward rapid diagnostics and more efficient workflows, aligning with NHS goals to expand diagnostic access and reduce delays. Although fully autonomous operation is still in development, the current prototype showcases how robotics and AI can enhance medical imaging, making vital heart assessments faster and more widely available.

This breakthrough indicates a future where robotic systems could play a crucial role in community health and emergency settings, transforming cardiac diagnostics and improving patient care across healthcare systems.

source: https://medicalxpress.com/news/2025-09-ai-powered-robot-echocardiograms-alleviate.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Women’s Brains Show Early Immune System Decline Due to Alcohol Use Disorder

Emerging research reveals that alcohol use disorder causes early decline in brain immune cells in women, increasing their risk for cognitive and emotional problems. New findings highlight sex-specific neural impacts of alcohol and the need for tailored therapies.

FDA Approves Monjuvi (Tafasitamab) for Advanced Follicular Lymphoma Treatment

The FDA has approved Monjuvi (tafasitamab) combined with rituximab and lenalidomide for adults with relapsed or refractory follicular lymphoma, offering new hope in chronic lymphoma management.

Research Reveals Insufficient Evidence Supporting Air-Cleaning Technologies for Respiratory Infection Prevention

A new study reveals significant gaps in scientific evidence supporting the effectiveness and safety of indoor air-cleaning technologies aimed at preventing respiratory infections like COVID-19 and the flu. Experts call for more real-world research and safety evaluations to guide public health measures.